HO2 — DR Horton Income Statement
0.000.00%
Last trade - 00:00- €40.05bn
- €43.10bn
- $34.25bn
- 52
- 47
- 46
- 43
Annual income statement for DR Horton, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 27,774 | 33,480 | 35,460 | 36,801 | 34,250 |
| Cost of Revenue | |||||
| Gross Profit | 7,900 | 10,565 | 9,431 | 9,590 | 8,231 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 22,418 | 25,850 | 29,146 | 30,517 | 29,511 |
| Operating Profit | 5,356 | 7,630 | 6,315 | 6,285 | 4,740 |
| Net Income Before Taxes | 5,356 | 7,630 | 6,315 | 6,285 | 4,740 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4,191 | 5,896 | 4,795 | 4,806 | 3,621 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 4,176 | 5,858 | 4,746 | 4,756 | 3,585 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 4,176 | 5,858 | 4,746 | 4,756 | 3,585 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 11.5 | 16.7 | 14 | 14.5 | 11.9 |
| Dividends per Share |